What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Psoriasis
His primary scientific interests are in Psoriasis, Dermatology, Internal medicine, Psoriatic arthritis and Adverse effect.
He studies Psoriasis Area and Severity Index, a branch of Psoriasis.
Mark Lebwohl interconnects Clinical trial and Chemotherapy in the investigation of issues within Dermatology.
In his study, Gastroenterology is strongly linked to Placebo, which falls under the umbrella field of Internal medicine.
In his study, which falls under the umbrella issue of Psoriatic arthritis, Physical therapy is strongly linked to Patient satisfaction.
His research in Adverse effect intersects with topics in Discontinuation, Pimecrolimus and Atopic dermatitis.
His most cited work include:
- Secukinumab in plaque psoriasis--results of two phase 3 trials. (1146 citations)
- Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics (923 citations)
- The Impact of Psoriasis on Quality of Life: Results of a 1998 National Psoriasis Foundation Patient-Membership Survey (828 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Dermatology, Psoriasis, Internal medicine, Adverse effect and Clinical trial.
In his works, Mark Lebwohl conducts interdisciplinary research on Dermatology and In patient.
Mark Lebwohl merges In patient with Moderate to severe psoriasis in his study.
His biological study spans a wide range of topics, including Randomized controlled trial, Surgery and Ustekinumab.
His Internal medicine research is multidisciplinary, relying on both Gastroenterology and Placebo.
His studies deal with areas such as Adalimumab and Infliximab as well as Etanercept.
He most often published in these fields:
- Dermatology (51.56%)
- Psoriasis (51.20%)
- Internal medicine (20.26%)
What were the highlights of his more recent work (between 2018-2021)?
- Psoriasis (51.20%)
- Dermatology (51.56%)
- Internal medicine (20.26%)
In recent papers he was focusing on the following fields of study:
His main research concerns Psoriasis, Dermatology, Internal medicine, In patient and Plaque psoriasis.
His study in Psoriasis is interdisciplinary in nature, drawing from both Randomized controlled trial and Clinical trial.
His Dermatology research is multidisciplinary, incorporating elements of Moderate to severe and Lotion.
His Internal medicine research includes themes of Gastroenterology and Placebo.
His Psoriasis Area and Severity Index study combines topics in areas such as Quality of life and Ustekinumab.
His Psoriatic arthritis research incorporates themes from Epidemiology and Intensive care medicine.
Between 2018 and 2021, his most popular works were:
- Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. (169 citations)
- Psoriasis: Which therapy for which patient: Psoriasis comorbidities and preferred systemic agents (110 citations)
- Psoriasis: Which therapy for which patient: Focus on special populations and chronic infections (101 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Cancer
The scientist’s investigation covers issues in Psoriasis, Internal medicine, Psoriasis Area and Severity Index, Adverse effect and Dermatology.
His study of Psoriatic arthritis is a part of Psoriasis.
The study incorporates disciplines such as Gastroenterology and Placebo in addition to Internal medicine.
The Psoriasis Area and Severity Index study combines topics in areas such as Dermatology Life Quality Index, Quality of life and Ustekinumab, Brodalumab.
In his research, Interim analysis, Placebo-controlled study, Hair loss and Calcipotriene is intimately related to Clinical endpoint, which falls under the overarching field of Adverse effect.
His work on Apremilast, Plaque psoriasis and Intense pulsed light as part of general Dermatology research is frequently linked to In patient and Pulse light, bridging the gap between disciplines.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
